Cargando…
Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets
Massive outbreaks of porcine epidemic diarrhea virus (PEDV) recurred in South Korea in 2013–2014 and affected approximately 40% of the swine breeding herds across the country, incurring a tremendous financial impact on producers and consumers. Despite the nationwide use of commercially available att...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126956/ https://www.ncbi.nlm.nih.gov/pubmed/27185262 http://dx.doi.org/10.1016/j.vetimm.2016.04.009 |
_version_ | 1783516257536966656 |
---|---|
author | Baek, Pil-Soo Choi, Hwan-Won Lee, Sunhee Yoon, In-Joong Lee, Young Ju Lee, Du Sik Lee, Seungyoon Lee, Changhee |
author_facet | Baek, Pil-Soo Choi, Hwan-Won Lee, Sunhee Yoon, In-Joong Lee, Young Ju Lee, Du Sik Lee, Seungyoon Lee, Changhee |
author_sort | Baek, Pil-Soo |
collection | PubMed |
description | Massive outbreaks of porcine epidemic diarrhea virus (PEDV) recurred in South Korea in 2013–2014 and affected approximately 40% of the swine breeding herds across the country, incurring a tremendous financial impact on producers and consumers. Despite the nationwide use of commercially available attenuated and inactivated vaccines in South Korea, PEDV has continued to plague the domestic pork industry, raising concerns regarding their protective efficacies and the need for new vaccine development. In a previous study, we isolated and serially cultivated a Korean PEDV epidemic strain, KOR/KNU-141112/2014, in Vero cells. With the availability of a cell culture-propagated PEDV strain, we are able to explore vaccination and challenge studies on pigs. Therefore, the aim of the present study was to produce an inactivated PEDV vaccine using the KNU-141112 strain and evaluate its effectiveness in neonatal piglets. Pregnant sows were immunized intramuscularly with the inactivated adjuvanted monovalent vaccine at six and three weeks prior to farrowing. Six-day-old piglets born to vaccinated or unvaccinated sows were challenged with the homogeneous KNU-141112 virus. The administration of the inactivated vaccine to sows greatly increased the survival rate of piglets challenged with the virulent strain, from 0% to approximately 92% (22/24), and significantly reduced diarrhea severity including viral shedding in feces. In addition, litters from unvaccinated sows continued to lose body weight throughout the experiment, whereas litters from vaccinated sows started recovering their daily weight gain at 7 days after the challenge. Furthermore, strong neutralizing antibody responses to PEDV were verified in immunized sows and their offspring, but were absent in the unvaccinated controls. Altogether, our data demonstrated that durable lactogenic immunity was present in dams administrated with the inactivated vaccine and subsequently conferred critical passive immune protection to their own litters against virulent PEDV infection. |
format | Online Article Text |
id | pubmed-7126956 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71269562020-04-08 Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets Baek, Pil-Soo Choi, Hwan-Won Lee, Sunhee Yoon, In-Joong Lee, Young Ju Lee, Du Sik Lee, Seungyoon Lee, Changhee Vet Immunol Immunopathol Article Massive outbreaks of porcine epidemic diarrhea virus (PEDV) recurred in South Korea in 2013–2014 and affected approximately 40% of the swine breeding herds across the country, incurring a tremendous financial impact on producers and consumers. Despite the nationwide use of commercially available attenuated and inactivated vaccines in South Korea, PEDV has continued to plague the domestic pork industry, raising concerns regarding their protective efficacies and the need for new vaccine development. In a previous study, we isolated and serially cultivated a Korean PEDV epidemic strain, KOR/KNU-141112/2014, in Vero cells. With the availability of a cell culture-propagated PEDV strain, we are able to explore vaccination and challenge studies on pigs. Therefore, the aim of the present study was to produce an inactivated PEDV vaccine using the KNU-141112 strain and evaluate its effectiveness in neonatal piglets. Pregnant sows were immunized intramuscularly with the inactivated adjuvanted monovalent vaccine at six and three weeks prior to farrowing. Six-day-old piglets born to vaccinated or unvaccinated sows were challenged with the homogeneous KNU-141112 virus. The administration of the inactivated vaccine to sows greatly increased the survival rate of piglets challenged with the virulent strain, from 0% to approximately 92% (22/24), and significantly reduced diarrhea severity including viral shedding in feces. In addition, litters from unvaccinated sows continued to lose body weight throughout the experiment, whereas litters from vaccinated sows started recovering their daily weight gain at 7 days after the challenge. Furthermore, strong neutralizing antibody responses to PEDV were verified in immunized sows and their offspring, but were absent in the unvaccinated controls. Altogether, our data demonstrated that durable lactogenic immunity was present in dams administrated with the inactivated vaccine and subsequently conferred critical passive immune protection to their own litters against virulent PEDV infection. Elsevier B.V. 2016-06 2016-04-25 /pmc/articles/PMC7126956/ /pubmed/27185262 http://dx.doi.org/10.1016/j.vetimm.2016.04.009 Text en © 2016 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Baek, Pil-Soo Choi, Hwan-Won Lee, Sunhee Yoon, In-Joong Lee, Young Ju Lee, Du Sik Lee, Seungyoon Lee, Changhee Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets |
title | Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets |
title_full | Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets |
title_fullStr | Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets |
title_full_unstemmed | Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets |
title_short | Efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets |
title_sort | efficacy of an inactivated genotype 2b porcine epidemic diarrhea virus vaccine in neonatal piglets |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126956/ https://www.ncbi.nlm.nih.gov/pubmed/27185262 http://dx.doi.org/10.1016/j.vetimm.2016.04.009 |
work_keys_str_mv | AT baekpilsoo efficacyofaninactivatedgenotype2bporcineepidemicdiarrheavirusvaccineinneonatalpiglets AT choihwanwon efficacyofaninactivatedgenotype2bporcineepidemicdiarrheavirusvaccineinneonatalpiglets AT leesunhee efficacyofaninactivatedgenotype2bporcineepidemicdiarrheavirusvaccineinneonatalpiglets AT yooninjoong efficacyofaninactivatedgenotype2bporcineepidemicdiarrheavirusvaccineinneonatalpiglets AT leeyoungju efficacyofaninactivatedgenotype2bporcineepidemicdiarrheavirusvaccineinneonatalpiglets AT leedusik efficacyofaninactivatedgenotype2bporcineepidemicdiarrheavirusvaccineinneonatalpiglets AT leeseungyoon efficacyofaninactivatedgenotype2bporcineepidemicdiarrheavirusvaccineinneonatalpiglets AT leechanghee efficacyofaninactivatedgenotype2bporcineepidemicdiarrheavirusvaccineinneonatalpiglets |